Catalent to purchase Metrics Contract Services from Mayne Pharma
Metrics’ Greenville facility will be integrated into oral development and manufacturing network of Catalent.
Vishnu Priyan
Latest articles
All Articles
Pfizer signs agreement to acquire biopharma firm GBT for $5.4bn
GBT takeover complements and boosts Pfizer’s expertise in rare haematology.
US FDA grants approval for Orion-Bayer’s Nubeqa combo for prostate cancer
The darolutamide combination treatment substantially lowered mortality risk by 32.5% in mHSPC patients.
AstraZeneca-Daiichi Sankyo’s Enhertu gets US FDA approval for breast cancer
The approval was based on findings from the Phase III DESTINY-Breast04 trial of Enhertu.
US FDA approves Pfizer-Myovant’s Myfembree for endometriosis pain
The companies will co-market the drug in the region and will be made available soon.
EC grants approval for Merck-AstraZeneca’s Lynparza for breast cancer
The approval was based on the Phase III OlympiA clinical trial of Lynparza versus placebo.
Amgen to acquire biopharma firm ChemoCentryx for $3.7bn
The board of directors of Amgen and ChemoCentryx has granted unanimous approval for the acquisition.
Gilead Sciences signs agreement to acquire MiroBio for $405m
Gilead will gain access to the discovery platform and complete line of the immune inhibitory receptor agonists of MiroBio.
Moderna reports total revenues of $4.7bn in Q2 2022
Four vaccines for infectious diseases are currently in the Phase III development stage.